Results for tag: "Neupogen"

Neupogen is a drug used in the treatment of cancer. It is a granulocyte colony-stimulating factor (G-CSF) that helps the body produce more white blood cells, which are important for fighting infection. Neupogen is used to reduce the risk of infection in patients with certain types of cancer, such as leukemia and lymphoma, who are receiving chemotherapy or radiation therapy. It is also used to reduce the risk of infection in patients undergoing bone marrow transplantation. Neupogen is available in both injectable and subcutaneous forms. The Neupogen market is highly competitive, with several major players in the oncology drug market. These include Amgen, Novartis, Pfizer, and Roche. Each of these companies has developed their own version of Neupogen, and they compete for market share. In addition, there are several smaller companies that produce generic versions of Neupogen. These companies are often able to offer lower prices than the major players, making them attractive to patients who are looking for an affordable treatment option. Show Less Read more